We validated localization and overexpression of SFRP2 in tumor endothelium at the protein level as shown by immunohistochemistry in breast, colon, pancreas, renal, prostate, hepatocellular carcinoma, and angiosarcoma [8]. Here, SFRP2 is linked to angiosarcoma.